Henri Huttunen

Henri Huttunen Email and Phone Number

Chief Scientific Officer (Cso) At Herantis Pharma Plc. @ Herantis Pharma Plc

Henri Huttunen's Contact Details

Henri Huttunen work email

Henri Huttunen personal email

n/a

Henri Huttunen's Current Company Details

Herantis Pharma Plc

Chief Scientific Officer (Cso) At Herantis Pharma Plc.

Henri Huttunen Work Experience Details

  • Chief Scientific Officer (Cso)
    Herantis Pharma Plc Dec 2009 - Present
    Espoo, Southern Finland, Fi
    I cofounded Herantis Pharma Plc (founded as Hermo Pharma Ltd.) in 2008 and served as the first CEO until late 2009. Since 2010 I have served as the Chief Scientific Officer of the company. In April 2014, Hermo Pharma merged with Laurantis Pharma, and the new company listed in NASDAQ OMX Helsinki First North marketplace in June 2014.
  • Docent (Adjunct Professor) In Neurobiology, Principle Investigator
    University Of Helsinki Mar 2008 - Present
    Helsinki, Fi
    As a principle investigator, I am running a research laboratory that currently focuses on molecular mechanisms of neurodegenerative diseases, mainly related to Alzheimer's disease and Parkinson's diseases. In 2009-2014, I was an Academy Research Fellow (Academy of Finland). The lab operates at the Neuroscience Center, Viikki campus of the University of Helsinki.
  • Chief Executive Officer, Co-Founder
    Hermo Pharma Ltd. Jun 2008 - Dec 2009
    Hermo Pharma is a drug discovery company in the field of neurological disease, which I co-founded in 2008. I served as the first CEO setting up the operations and running the first round of financing. During this time, the company initiated its first strategic partnerships and prepared to launch its first clinical study (amblyopia (lazy eye) in adults; phase 2 study started in 2011).
  • Instructor In Neurology
    Massachusetts General Hospital, Harvard Medical School Jan 2007 - Mar 2008
    Boston, Ma, Us
    Conducting basic and translational research in Alzheimer's disease and related dementias at Massachusetts General Hospital, Harvard Medical School.
  • Postdoctoral Research Fellow
    Massachusetts General Hospital, Harvard Medical School Oct 2003 - Dec 2006
    Boston, Ma, Us
    Studying the role of cholesterol in APP processing, a key pathogenic event in Alzheimer's disease, at the MassGeneral Institute of Neurodegenerative Disease.
  • Research Scientist
    Orion Pharma Jan 2003 - Sep 2003
    Espoo, Fi
    Planning, executing and reporting experiments dealing with central nervous system drug candidates in the Drug Discovery division of Orion Pharma in Turku, Finland.
  • Research Scientist/Graduate Student
    University Of Helsinki Jan 1997 - Dec 2002
    Helsinki, Fi
    Studying the molecular signaling mechanisms and the role of cell migration in neuronal development and tumor metastasis. Ph.D. thesis "Role of RAGE as an Amphoterin Receptor: From Development to Disease" was awarded the Best Thesis in Neuroscience in Finland in 2002 award as well as the Best Thesis in Viikki Biocenter 2002 (shared) award.
  • Research Assistant/Undergraduate Student
    University Of Helsinki Sep 1995 - Dec 1996
    Helsinki, Fi
    Studying the functional role of two novel growth factor/cytokine-type molecules and their receptors in neuronal develpment.

Henri Huttunen Education Details

  • University Of Helsinki
    Neuroscience
  • University Of Helsinki
    Chemistry

Frequently Asked Questions about Henri Huttunen

What company does Henri Huttunen work for?

Henri Huttunen works for Herantis Pharma Plc

What is Henri Huttunen's role in his/her workplace?

Henri Huttunen's role in his/her workplace is Chief Scientific Officer (Cso) At Herantis Pharma Plc..

What is Henri Huttunen's email address?

Henri Huttunen's email address is he****@****inki.fi